Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 8, Issue 5, 2006, Pages

  Sarafidis, Panteleimon A ^a   Bakris, George L ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; INSULIN; PROPANOLAMINE DERIVATIVE;

ARTICLE; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; CARBAZOLES; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERTENSION; INSULIN; PROPANOLAMINES; VASODILATION;

EID: 33745946543     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2005.04679.x     Document Type: Article

References (0)